HuGE Literature Finder
Records
1
-
30
| [Risk factors for leukemia transformation in patients with myelodysplastic syndromes]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (10): 818-825. Zhao S Y, Xu Z F, Qin T J, Qu S Q, Li C W, Jia Y J, Pan L J, Li B, Gao Q Y, Jiao M, Huang H J, Xiao Z |
| An NGS based MRD evaluation from acute myeloid leukemia patients. International journal of laboratory hematology 2023 2 . Chen Bin, Wang Lingling, Wang Zhe, Zhang Hong, Chen Long, Zhang Lei, Li Jing, Yan Xiaoyan, Zhao Miaoqing, Lin Yani, Ru K |
| Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. American journal of hematology 2023 1 98 (3): 398-407. Lee Wan-Hsuan, Lin Chien-Chin, Tsai Cheng-Hong, Tien Feng-Ming, Lo Min-Yen, Ni Sao-Chih, Yao Ming, Tseng Mei-Hsuan, Kuo Yuan-Yeh, Liu Ming-Chih, Tang Jih-Luh, Sun Hsun-I, Chuang Yi-Kuang, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells. BMC cancer 2023 3 23 (1): 255. Li Weijing, Liu Shugang, Wang Chanjuan, Cui Lei, Zhao Xiaoxi, Liu Wei, Zhang Ruidong, Li Zhiga |
| Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China. Cancer medicine 2023 2 . Li Junnan, Pei Li, Liang Simin, Xu Shuangnian, Wang Yi, Wang Xiao, Liao Yi, Zhan Qian, Cheng Wei, Yang Zesong, Tang Xiaoqiong, Zhang Hongbin, Xiao Qing, Chen Jianbin, Liu Lin, Wang |
| Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
| Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia. Cancer science 2023 1 . Wakita Satoshi, Marumo Atsushi, Morita Kaoru, Kako Shinichi, Toya Takashi, Najima Yuho, Doki Noriko, Kanda Junya, Kuroda Junya, Mori Shinichiro, Satake Atsushi, Usuki Kensuke, Ueki Toshimitsu, Uoshima Nobuhiko, Kobayashi Yutaka, Kawata Eri, Nakayama Kazutaka, Nagao Yuhei, Shono Katsuhiro, Shibusawa Motoharu, Tadokoro Jiro, Hagihara Masao, Uchiyama Hitoji, Uchida Naoyuki, Kubota Yasushi, Kimura Shinya, Nagoshi Hisao, Ichinohe Tatsuo, Kurosawa Saiko, Motomura Sayuri, Hashimoto Akiko, Muto Hideharu, Sato Eriko, Ogata Masao, Mitsuhashi Kenjiro, Ando Jun, Tashiro Haruko, Sakaguchi Masahiro, Yui Shunsuke, Arai Kunihito, Kitano Tomoaki, Miyata Miho, Arai Haruka, Kanda Masayuki, Itabashi Kako, Fukuda Takahiro, Kanda Yoshinobu, Yamaguchi Hiro |
| Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leukemia & lymphoma 2023 3 1-9. Ramia de Cap Maximiliano, Wu Leo P, Hirt Christian, Pihan German A, Patel Sanjay S, Tam Wayne, Bueso-Ramos Carlos E, Kanagal-Shamanna Rashmi, Raess Philipp W, Siddon Alexa, Narayanan Damodaran, Morgan Elizabeth A, Pinkus Geraldine S, Mason Emily F, Hsi Eric D, Rogers Heesun J, Toth Laura, Foucar Kathryn, Hurwitz Stephanie N, Bagg Adam, Rets Anton, George Tracy I, Orazi Attilio, Arber Daniel A, Hasserjian Robert P, Weinberg Olga K, |
| Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes. Hematology (Amsterdam, Netherlands) 2023 2 28 (1): 2180704. Papadopoulou Vasiliki, Schoumans Jacqueline, Basset Valentin, Solly Françoise, Pasquier Jérôme, Blum Sabine, Spertini Olivi |
| The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia. Cancer medicine 2023 3 . Chen Xian, Tian Chuchu, Hao Zhuanghui, Pan Lingang, Hong Minglin, Wei Wei, Muyey Daniel Muteb, Wang Hongwei, Chen Xiuh |
| [Clinical Outcomes and Prognostic Factors of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 2022 Oct 30 (5): 1577-1585. Lou Dian, Liu Li, Yan Xue-Qian, Gu Fang-Na, Zhang Yang-Ping, Qin Wei-W |
| [Analysis of Gene Mutation Characteristics and Prognosis of Elderly Patients with Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 2022 Jun 30 (3): 755-759. Zhou Nai-Cen, Li Guo-Hui, Qin Wei-Wei, Wang Wen-Qing, Guo Huai-Peng, Liu Cong, Liu |
| Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations. JACC. CardioOncology 2022 Mar 4 (1): 38-49. Calvillo-Argüelles Oscar, Schoffel Alice, Capo-Chichi José-Mario, Abdel-Qadir Husam, Schuh Andre, Carrillo-Estrada Montserrat, Liu Shiying, Gupta Vikas, Schimmer Aaron D, Yee Karen, Shlush Liran I, Natarajan Pradeep, Thavendiranathan Paaladine |
| [Analysis of clinical significance and prognostic impact of TET2 single nucleotide polymorphism I1762V in patients with acute myeloid leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2022 4 43 (3): 241-246. Li Y W, Guo Z, Wang L L, Zhou L, Lyu X D, Song Y |
| [Gene Mutation and Clinical Characteristics of Patients with Acute Leukemia]. Zhongguo shi yan xue ye xue za zhi 2022 12 30 (6): 1693-1699. Yang Jie, Yang Yong-Bin, Wang Rui-Cang, Liu Jing-Yue, Li Yan, Yuan Jun, Li Jie, Zhang Xiao-Xia, Gao Xiao-Han, Hao Hong-Li |
| Case Report: Mature Plasmacytoid Dendritic Cell Proliferation Associated With a Lymphoid Neoplasm. Frontiers in oncology 2022 7 12 903113. Fei Fei, Liedtke Michaela, Silva Osc |
| Clinical characteristics and prognostic analysis of acute myeloid leukemia patients with PTPN11 mutations. Hematology (Amsterdam, Netherlands) 2022 11 27 (1): 1184-1190. Sun Yueyue, Zhang Fenghong, Huo Li, Cai Wenzhi, Wang Qinrong, Wen Lijun, Yan Lingzhi, Shen Hongjie, Xu Xiaoyu, Chen Suni |
| Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia. Asian Pacific journal of cancer prevention : APJCP 2022 12 23 (12): 4299-4305. Aref Salah, Sallam Nahed, Abd Elaziz Sherin, Salama Osama, Al Ashwah Shaimaa, Ayed Moham |
| Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with RUNX1-RUNX1T1 or CBFB-MYH11 Fusions. Turkish journal of haematology : official journal of Turkish Society of Haematology 2022 4 39 (2): 84-93. Qin Wei, Chen Xiayu, Shen Hong Jie, Wang Zheng, Cai Xiaohui, Jiang Naike, Hua Haiyi |
| Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid Leukemia. Clinical interventions in aging 2022 17 1187-1197. Li Fengli, Li Na, Wang Anyou, Liu X |
| Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. Leukemia 2022 09 36 (9): 2218-2227. Jahn Nikolaus, Jahn Ekaterina, Saadati Maral, Bullinger Lars, Larson Richard A, Ottone Tiziana, Amadori Sergio, Prior Thomas W, Brandwein Joseph M, Appelbaum Frederick R, Medeiros Bruno C, Tallman Martin S, Ehninger Gerhard, Heuser Michael, Ganser Arnold, Pallaud Celine, Gathmann Insa, Krzykalla Julia, Benner Axel, Bloomfield Clara D, Thiede Christian, Stone Richard M, Döhner Hartmut, Döhner Konstan |
| Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials. Haematologica 2022 11 . González-Gil Celia, Morgades Mireia, Lopes Thaysa, Fuster-Tormo Francisco, García-Chica Jesús, Zhao Ran, Montesinos Pau, Torrent Anna, Diaz-Beya Marina, Coll Rosa, Hermosín Lourdes, Mercadal Santiago, González-Campos José, Zamora Lurdes, Artola Teresa, Vall-Llovera Ferran, Tormo Mar, Gil-Cortés Cristina, Barba Pere, Novo Andrés, Ribera Jordi, Bernal Teresa, De Ugarriza Paula López, Queipo María-Paz, Martínez-Sánchez Pilar, Giménez Alicia, González-Martínez Teresa, Cladera Antonia, Cervera José, Fernández-Martín Rosa, Ardaiz María Ángeles, Vidal María Jesús, Baena Ángela, López-Bigas Nuria, Bigas Anna, Maciejewski Jaroslaw, Orfao Alberto, Ribera Josep Maria, Genescà Eulal |
| Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia. Cancer 2022 11 129 (2): 245-254. Han Haohao, Yao Yifang, Wang Hong, Zhou Meng, Zhang Ziyan, Xu Xiaoyan, Qi Jiaqian, Liu Yuejun, Wu Depei, Han Y |
| Measurable residual disease detected by flow cytometry independently predicts prognoses of NPM1-mutated acute myeloid leukemia. Annals of hematology 2022 11 102 (2): 337-347. Zhang Yun-Wei, Su Long, Tan Ye-Hui, Lin Hai, Liu Xiao-Liang, Liu Qiu-Ju, Sun Jing-Nan, Zhang Ming, Du Ya-Zhe, Song Fei, Han Wei, Gao Su-J |
| Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals. Blood advances 2022 5 6 (14): 4174-4184. van Zeventer Isabelle A, de Graaf Aniek O, Koorenhof-Scheele Theresia N, van der Reijden Bert A, van der Klauw Melanie M, Dinmohamed Avinash G, Diepstra Arjan, Schuringa Jan Jacob, Malcovati Luca, Huls Gerwin, Jansen Joop |
| NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia. Oncoimmunology 2022 5 11 (1): 2073050. Kuželová Kate?ina, Brodská Barbora, Marková Jana, Petrá?ková Martina, Schetelig Johannes, Ransdorfová Šárka, Gašová Zdenka, Šálek Cyr |
| Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia. Leukemia 2022 7 36 (9): 2328-2337. Groarke Emma M, Patel Bhavisha A, Shalhoub Ruba, Gutierrez-Rodrigues Fernanda, Desai Parth, Leuva Harshraj, Zaimoku Yoshitaka, Paton Casey, Spitofsky Nina, Lotter Jennifer, Rios Olga, Childs Richard W, Young David J, Dulau-Florea Alina, Dunbar Cynthia E, Calvo Katherine R, Wu Colin O, Young Neal |
| Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study. Leukemia & lymphoma 2022 4 63 (9): 2171-2179. Memoli Mara, Genthon Alexis, Favale Fabrizia, Lapusan Simona, Johnson Natacha, Adaeva Rosa, Deswarte Caroline, Battipaglia Giorgia, Malard Florent, Duléry Rémy, Brissot Eolia, Banet Anne, Van de Wyngaert Zoé, Mohty Mohamad, Delhommeau François, Legrand Ollivier, Hirsch Pier |
| Somatic mutation-associated risk index based on lncRNA expression for predicting prognosis in acute myeloid leukemia. Hematology (Amsterdam, Netherlands) 2022 6 27 (1): 659-671. Xu Qiang, Guo T |
| TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran. International journal of organ transplantation medicine 2022 5 12 (3): 12-20. Abedi E, Ramzi M, Karimi M, Yaghobi R, Mohammadi H, Bayat E, Moghadam M, Farokhian F, Dehghani M, Golafshan H A, Haghpanah |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: